AKT1 and breast cancer: In xenografts of breast cancer, the tumor growth rate and elevated levels of AKT and 3-phosphoinositide-dependent kinase-1 (PDK-1), an AKT stimulator, correlated with night-time light exposure and reduced levels of melatonin [106].